Recombinant Human ACOT11 Protein, GST-Tagged
Cat.No. : | ACOT11-167H |
Product Overview : | Human ACOT11 full-length ORF (BAB14734.1, 1 a.a. - 594 a.a.) recombinant protein with GST-tag at N-terminal. |
- Specification
- Gene Information
- Related Products
- Download
Description : | This gene encodes a member of the acyl-CoA thioesterase family which catalyse the conversion of activated fatty acids to the corresponding non-esterified fatty acid and coenzyme A. Expression of a mouse homolog in brown adipose tissue is induced by low temperatures and repressed by warm temperatures. Higher levels of expression of the mouse homolog has been found in obesity-resistant mice compared with obesity-prone mice, suggesting a role of acyl-CoA thioesterase 11 in obesity. Alternative splicing results in transcript variants. [provided by RefSeq, Nov 2010] |
Source : | Wheat Germ |
Species : | Human |
Tag : | GST |
Molecular Mass : | 93.6 kDa |
AA Sequence : | MIQNVGNHLRRGLASVFSNRTSRKS ALRAGNDSAMADGEGYRNPTEVQMS QLVLPCHTNQRGELSVGQLLKWIDT TACLSAERHAGCPCVTASMDDIYFE HTISVGQVVNIKAKVNRAFNSSMEV GIQVASEDLCSEKQWNVCKALATFV ARREITKVKLKQITPRTEEEKMEHS VAAERRRMRLVYADTIKDLLANCAI QGDLESRDCSRMVPAEKTRVESVEL VLPPHANHQGNTFGGQIMAWMENVA TIAASRLCRAHPTLKAIEMFHFRGP SQVGDRLVLKAIVNNAFKHSMEVGV CVEAYRQEAETHRRHINSAFMTFVV LDADDQPQLLPWIRPQPGDGERRYR EASARKKIRLDRKYIVSCKQTEVPL SVPWDPSNQVYLSYNNVSSLKMLVA KDNWVLSSEISQVRLYTLEDDKFLS FHMEMVVHVDAAQAFLLLSDLRQRP EWDKHYRSVELVQQVDEDDAIYHVT SPALGGHTKPQDFVILASRRKPCDN GDPYVIALRSVTLPTHRETPEYRRG ETLCSGFCLWREGDQLTKVSYYNQA TPGVLNYVTTNVAGLSSEFYTTFKA CEQFLLDNRNDLAPSLQTL |
Applications : | Enzyme-linked Immunoabsorbent Assay Western Blot (Recombinant protein) Antibody Production Protein Array |
Notes : | Best use within three months from the date of receipt of this protein. |
Storage : | Store at -80 centigrade. Aliquot to avoid repeated freezing and thawing. |
Storage Buffer : | 50 mM Tris-HCI, 10 mM reduced Glutathione, pH=8.0 in the elution buffer. |
Gene Name : | ACOT11 acyl-CoA thioesterase 11 [ Homo sapiens ] |
Official Symbol : | ACOT11 |
Synonyms : | ACOT11; acyl-CoA thioesterase 11; THEA, thioesterase, adipose associated; acyl-coenzyme A thioesterase 11; BFIT; BFIT1; KIAA0707; StAR related lipid transfer (START) domain containing 14; STARD14; THEM1; START domain containing 14; acyl-CoA thioester hydrolase 11; adipose-associated thioesterase; brown fat-inducible thioesterase; thioesterase, adipose associated; thioesterase superfamily member 1; StAR-related lipid transfer (START) domain containing 14; THEA; DKFZp667O1916; |
Gene ID : | 26027 |
mRNA Refseq : | NM_015547 |
Protein Refseq : | NP_056362 |
MIM : | 606803 |
UniProt ID : | Q8WXI4 |
Products Types
◆ Recombinant Protein | ||
BFIT-2436H | Recombinant human BFIT, His-tagged | +Inquiry |
ACOT11-9296H | Recombinant Human ACOT11, GST-tagged | +Inquiry |
◆ Lysates | ||
ACOT11-6HCL | Recombinant Human ACOT11 lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (12)
Ask a questionYes, ACOT11 protein is a potential target for drug development, especially for metabolic disorders and cancer.
Yes, ACOT11 protein is a potential target for drug development in metabolic disorders, cancer research, and other areas. Targeting its activity could have therapeutic benefits for various diseases and conditions.
ACOT11 protein is not commonly used in diagnostic tests, but changes in its expression or activity may serve as biomarkers for certain diseases or conditions.
ACOT11 protein may have potential applications in the treatment of metabolic disorders such as obesity and diabetes, as well as in cancer research and sports nutrition.
ACOT11 protein is a specific type of enzyme that is involved in the breakdown of long-chain fatty acids. It has a unique structure and function compared to other enzymes involved in fatty acid metabolism, such as lipases and acyl-CoA synthetases.
ACOT11 protein may have potential anticancer effects by regulating cancer cell metabolism and inducing cell death in cancer cells.
ACOT11 protein may have therapeutic implications for the treatment of metabolic disorders such as obesity and diabetes, as well as certain types of cancer. It may also be a target for drug development to enhance fatty acid oxidation.
ACOT11 protein can help to regulate lipid metabolism and reduce lipid accumulation in tissues, which can be beneficial in preventing and treating metabolic disorders such as obesity and diabetes.
Research areas exploring the potential of ACOT11 protein include metabolic disorders such as diabetes and obesity, as well as cancer research and drug development.
ACOT11 protein is regulated by various factors, including hormones, nutrients, and metabolic pathways. Its activity can be affected by insulin, glucagon, and other hormones involved in the regulation of lipid metabolism.
One challenge is understanding the complex role of ACOT11 in lipid metabolism and its potential off-target effects on other metabolic pathways. Developing selective ACOT11 inhibitors or modulators with good pharmacokinetic properties is also a challenge.
ACOT11 protein is still being studied and has not yet been approved for specific treatments or products. However, it has been identified as a potential target for drug development in metabolic disorders and cancer research.
Ask a Question for All ACOT11 Products
Required fields are marked with *
My Review for All ACOT11 Products
Required fields are marked with *
Inquiry Basket